Bruderman Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bruderman Asset Management's PFE Position: Q4 2019 in Review
Bruderman Asset Management sold out of Pfizer (PFE) in Q4 2019, closing a stake of 8,658 shares — an estimated $304K sold.
Bruderman Asset Management first reported a position in PFE in Q1 2015 and held it in 19 quarters. The position peaked at $16.2M in Q3 2018. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.
- Bruderman Asset Management reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
- Bruderman Asset Management sold 8,658 Pfizer shares in Q4 2019, an estimated $304K.
- Bruderman Asset Management first reported a position in Pfizer in Q1 2015 and held it in 19 quarters.
- Bruderman Asset Management's Pfizer position peaked at $16.2M in Q3 2018.
- 2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.
Based on Bruderman Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.